Shapiro AM - Search Results

1

A novel redox-active metalloporphyrin reduces reactive oxygen species and inflammatory markers but does not improve marginal mass engraftment in a murine donation after circulatory death islet transplantation model.

Bruni A, Pepper AR, Gala-Lopez B, Pawlick R, Abualhassan N, Crapo JD, Piganelli JD, Shapiro AM. Bruni A, et al. Among authors: shapiro am. Islets. 2016 Jul 3;8(4):e1190058. doi: 10.1080/19382014.2016.1190058. Islets. 2016. PMID: 27220256 Free PMC article.

2

Successful islet transplantation: continued insulin reserve provides long-term glycemic control.

Ryan EA, Lakey JR, Paty BW, Imes S, Korbutt GS, Kneteman NM, Bigam D, Rajotte RV, Shapiro AM. Ryan EA, et al. Among authors: shapiro am. Diabetes. 2002 Jul;51(7):2148-57. doi: 10.2337/diabetes.51.7.2148. Diabetes. 2002. PMID: 12086945

3

Clinical islet transplant: current and future directions towards tolerance.

Shapiro AM, Nanji SA, Lakey JR. Shapiro AM, et al. Immunol Rev. 2003 Dec;196:219-36. doi: 10.1046/j.1600-065x.2003.00085.x. Immunol Rev. 2003. PMID: 14617207 Review.

4

Multiple combination therapies involving blockade of ICOS/B7RP-1 costimulation facilitate long-term islet allograft survival.

Nanji SA, Hancock WW, Anderson CC, Adams AB, Luo B, Schur CD, Pawlick RL, Wang L, Coyle AJ, Larsen CP, Shapiro AM. Nanji SA, et al. Among authors: shapiro am. Am J Transplant. 2004 Apr;4(4):526-36. doi: 10.1111/j.1600-6143.2004.00384.x. Am J Transplant. 2004. PMID: 15023144 Free article.

5

Risks and side effects of islet transplantation.

Ryan EA, Paty BW, Senior PA, Shapiro AM. Ryan EA, et al. Among authors: shapiro am. Curr Diab Rep. 2004 Aug;4(4):304-9. doi: 10.1007/s11892-004-0083-8. Curr Diab Rep. 2004. PMID: 15265474 Review.

6

Islet transplantation in patients with diabetes mellitus: choice of immunosuppression.

Nanji SA, Shapiro AM. Nanji SA, et al. Among authors: shapiro am. BioDrugs. 2004;18(5):315-28. doi: 10.2165/00063030-200418050-00004. BioDrugs. 2004. PMID: 15377174 Review.

7

The portal immunosuppressive storm: relevance to islet transplantation?

Shapiro AM, Gallant HL, Hao EG, Lakey JR, McCready T, Rajotte RV, Yatscoff RW, Kneteman NM. Shapiro AM, et al. Ther Drug Monit. 2005 Feb;27(1):35-7. doi: 10.1097/00007691-200502000-00008. Ther Drug Monit. 2005. PMID: 15665744

8

XIAP overexpression in islet beta-cells enhances engraftment and minimizes hypoxia-reperfusion injury.

Emamaullee J, Liston P, Korneluk RG, Shapiro AM, Elliott JF. Emamaullee J, et al. Among authors: shapiro am. Am J Transplant. 2005 Jun;5(6):1297-305. doi: 10.1111/j.1600-6143.2005.00891.x. Am J Transplant. 2005. PMID: 15888033 Free article. Review.

9

Strategic opportunities in clinical islet transplantation.

Shapiro AM, Lakey JR, Paty BW, Senior PA, Bigam DL, Ryan EA. Shapiro AM, et al. Transplantation. 2005 May 27;79(10):1304-7. doi: 10.1097/01.tp.0000157300.53976.2a. Transplantation. 2005. PMID: 15912095 Review.

10

Five-year follow-up after clinical islet transplantation.

Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, Lakey JR, Shapiro AM. Ryan EA, et al. Among authors: shapiro am. Diabetes. 2005 Jul;54(7):2060-9. doi: 10.2337/diabetes.54.7.2060. Diabetes. 2005. PMID: 15983207

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

554 results

Search Page

Filters